225Ac-A9-0941 An investigational actinium-225 radiotherapeutic targeting NTSR1 for pancreatic, colorectal, and other cancers in Alpha-9’s development pipeline.
Visit productCosigns Received
Be the first Cosign
Put your name behind 225Ac-A9-0941.
Add it to your Products I use list and share why you use it.